Calzinc Tablet

Quick links to important sections

Calzinc Tablet

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Calzinc Tablet

Property Description
Active Ingredients Magnesium Hydroxide, Calcium, Zinc, Vitamin D3
Form Tablet, Chewable Tablet, Oral Suspension
Pharmacological Class Nutritional Supplement, Antacid, Saline Laxative
Common Use Mineral deficiency, Heartburn, Occasional constipation
Origin Combination of Inorganic Compounds and Synthetic Vitamin D

What Type of Medicine is Calzinc Tablet?

The Calzinc Tablet is defined as an oral combination product that functions primarily as a Nutritional Supplement containing essential minerals and vitamins. It is a widely available, Over-the-Counter (OTC) medicine, commonly supplied as a solid tablet or, in some variations, a chewable tablet or liquid oral suspension. This preparation is a multimineral formulation, specifically positioned to support skeletal health across various adult patient groups and for its role in maintaining mineral homeostasis. Unlike single-ingredient supplements, Calzinc Tablet offers a convenient single-dose format that combines its agents.


Composition, Class, and General Purpose

The core active ingredients are the inorganic compounds Magnesium Hydroxide (a form of Milk of Magnesia), Calcium salts, and Zinc salts, complemented by the synthetic vitamin Cholecalciferol (Vitamin D3). The Magnesium Hydroxide component (Mg(OH)2) holds a specific dual classification, being both a high-level Antacid and a Saline Laxative. Its application for occasional constipation is characterized by its osmotic action.

This combination grants the product a specific dual therapeutic purpose. The formulation ensures the tablet supplies vital structural minerals necessary for bone mineral density support, while simultaneously leveraging the alkaline nature of the magnesium salt to help neutralize gastric acid. Consequently, the general purpose of the Calzinc Tablet is to address potential nutritional deficiencies and concurrently provide alleviation of discomfort associated with common, temporary symptoms of acid indigestion, such as episodic heartburn.

Regulatory References

  1. National Institutes of Health (NIH, MedlinePlus)
  2. NLM, MedlinePlus

What side effects are possible with Calzinc Tablet?

Possible side effects and safety information

The official safety profile for Calzinc Tablet is defined by adverse reactions classified primarily within gastrointestinal and metabolic systems, as documented in government regulatory labeling.


Frequency-Classified Adverse Reactions

Adverse effects are categorized by incidence based on regulatory standards:

  • Common: Gastrointestinal disturbances such as abdominal pain, nausea, diarrhea, vomiting, and flatulence are frequently listed.
  • Uncommon: Metabolic effects like Hypercalcaemia (elevated blood calcium) and Hypercalciuria (elevated urine calcium) are noted.
  • Rare: Reactions affecting the skin, including pruritus, rash, and urticaria, along with constipation, are documented.
  • Very Rare: Hypermagnesemia (elevated blood magnesium) has been reported.

Serious Reactions and Safety Constraints

The official documentation identifies serious adverse reactions, including Hypersensitivity Reactions (such as anaphylaxis and angioedema). A specific, rare risk associated with long-term, high-dose ingestion of calcium and alkali is Milk-Alkali Syndrome.

Safety constraints and limitations are explicitly noted for specific patient groups:

  • Renal Impairment: Patients with renal impairment or failure have an increased risk of developing Hypermagnesemia and related toxicity due to impaired excretion.
  • Existing Conditions: Use must be avoided in individuals with pre-existing conditions such as Hypervitaminosis D, Nephrolithiasis (kidney stones), or Severe Renal Insufficiency.
  • Duration-Related Patterns: Long-term administration of zinc salts is associated with a risk of Copper deficiency, a pattern defined in official prescribing information.

Structure of the Safety Profile

The regulatory safety summary structures the risks by separating common, typically gastrointestinal effects from less frequent, metabolic, and serious adverse reactions. This framework helps define how the risk of metabolic imbalances is primarily linked to factors like pre-existing renal impairment or long-term exposure, consistent with requirements from regulatory authorities.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Calzinc Tablet, a combination product, may lead to documented toxicities primarily involving Hypercalcemia and Hypermagnesemia. The clinical presentations officially documented in regulatory sources include severe gastrointestinal symptoms such as nausea, vomiting, severe diarrhea, and constipation, alongside neuromuscular signs like muscle weakness, lethargy, and confusion.


Life-Threatening Manifestations and Emergency Action

Overdosage is associated with a risk of severe, life-threatening outcomes, including respiratory depression, cardiac arrhythmias, and renal failure. The development of stupor or signs of a hypercalcemic crisis requires urgent attention. Regulators mandate that users seek immediate medical attention or contact a poison control center at once if overdosage is suspected.

Management and Monitoring

Management is strictly symptomatic and supportive. There is no specific antidote for the combination; however, official procedures include discontinuation of the product, aggressive intravenous fluid administration, and specialized therapies such as Intravenous Calcium Gluconate to antagonize magnesium's cardiotoxic effects. Hospital monitoring, including measurement of serum calcium and magnesium levels and ECG checks, is required in severe cases. Patients with impaired renal function are noted to be at increased risk of severe toxicity.

Therapeutic Uses of Calzinc Tablet

What Calzinc Tablet Treats: Main Uses and Benefits

The Calzinc Tablet formulation is commonly used to manage conditions across three distinct therapeutic domains.


Supporting Bone Health and Correcting Mineral Deficiencies

This core domain is relevant in contexts where additional symptomatic support for systemic imbalance is needed. The tablet is generally applied in situations involving low levels of essential nutrients, such as Calcium and Vitamin D deficiency, conditions where functional stability of the skeletal system becomes affected. It is commonly used across patient groups, including older adults and postmenopausal women. The medication is commonly used to help with: nutritional deficiencies, episodic heartburn, and occasional constipation. This provides support that helps ease the overall symptom burden by assisting with systemic balance related to bone health.

“The product may assist with systemic balance related to essential minerals during phases of increased physiological demand or insufficient dietary intake.”


Symptomatic Relief for Acute Digestive Discomfort

The medication generally offers symptomatic relief for acute gastrointestinal discomfort by addressing symptoms related to heightened physiological activity. It is applied in contexts where temporary assistance in symptom stabilization is needed for episodic heartburn and acid indigestion. This offers symptomatic relief that helps patients cope more steadily with difficult episodes, addressing the burning sensation and discomfort caused by irritative states.


Easing Occasional Bowel Irregularity

This use is applicable within clinical settings that involve acute or disruptive symptom patterns concerning the gastrointestinal tract. It is used for managing symptoms that interfere with daily comfort, specifically those associated with occasional constipation and difficulty passing stool. Applied in scenarios where additional management of discomfort is required, the product may assist with supporting functional stability by supporting patients during episodes of heightened discomfort.


Focus on Symptomatic Relief The tablet is considered relevant for easing symptoms that may appear suddenly, such as the burning of heartburn, and is used when short-term symptomatic assistance is needed.

Regulatory References

  1. Calcium, vitamin D, and your bones: MedlinePlus Medical Encyclopedia

Eligibility and Restrictions for Use

Eligibility and Contraindications for Calzinc Tablet

Calzinc Tablet's official eligibility profile is strictly defined by regulatory authorities for its combination of Calcium, Magnesium, Zinc, and Vitamin D3. The use of this product is contraindicated and must be avoided by patients with a known hypersensitivity to any component. Absolute non-eligibility also applies to individuals with Intestinal Obstruction Disorders or Inflammatory Bowel Disease (IBD), due to the presence of the laxative component.

Regulatory documents place specific limitations on high-risk populations. The medicine is not recommended for use in patients with Severe Renal Impairment due to the serious risk of Hypermagnesemia (magnesium toxicity). It is also contraindicated in patients with elevated mineral levels, specifically Hypercalcemia or Hyperphosphatemia.

Age-related eligibility rules state that the safety and effectiveness of the complete combination product have not been established for pediatric patients less than 18 years of age, restricting general eligibility to the adult population. For pregnancy and lactation, use is permitted but requires caution and must not exceed the officially documented Recommended Dietary Allowance (RDA), necessitating consultation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the interaction profile of Calzinc Tablet (Magnesium Hydroxide, Calcium, Zinc, Vitamin D3) across pharmacokinetic (PK) and pharmacodynamic (PD) mechanisms.

Pharmacokinetic Interactions and Administration Rules

Many interactions are chelation-based, where the mineral components bind to co-administered medicines, resulting in decreased systemic exposure of the co-administered drug. This PK effect necessitates mandatory timing separation rules for several drug classes.

Interacting Product Regulatory Requirement
Fluoroquinolone Antibiotics Administer at least 2 hours before or 6 hours after Calzinc Tablet.
Tetracycline Antibiotics Administer at least 3 hours before or 1 hour after Calzinc Tablet.
Levothyroxine Administer at least 4 hours apart.

Pharmacodynamic Interactions and Considerations

Co-administration with Thiazide Diuretics carries an officially recognized risk of Hypercalcemia due to additive effects on mineral balance. A documented PD interaction exists with Cardiac Glycosides (e.g., Digoxin), which may lead to an increased risk of Arrhythmias. Furthermore, the interaction profile notes that in patients with Renal Impairment, reduced mineral clearance heightens the risk of Hypermagnesemia and Hypercalcemia, intensifying interaction severity.

Mechanism of Action

How Calzinc Tablet Works


Local Gastrointestinal Chemical and Osmotic Action

The Magnesium Hydroxide component acts through two immediate, local mechanisms. In the stomach, it performs instantaneous chemical neutralization by reacting with hydrogen ions ( H^+), resulting in a localized pH elevation. In the colon, unabsorbed Magnesium ions generate a high osmotic gradient , drawing water into the intestinal lumen. This produces the physiological consequences of local pH elevation and increased intraluminal volume within the GI tract.


Systemic Regulation of Calcium Bioavailability

This mechanism is governed by Vitamin D3. When converted to its active form, Vitamin D acts as a ligand for the nuclear Vitamin D Receptor ( VDR), initiating gene transcription that increases the synthesis of intestinal calcium transport proteins. This process contributes to the modulation of Calcium absorption rate, affecting the systemic Calcium delivery. Magnesium is required to facilitate the conversion enzyme.


Cellular Modulation of Skeletal Matrix Integrity

Zinc influences the cellular machinery of bone by acting as a co-activator for key transcription factors like Runx2, which stimulates the growth and differentiation of bone-building cells ( osteoblasts). Simultaneously, Zinc modulates pathways that inhibit bone-resorbing cells ( osteoclasts), contributing to a net physiological shift that favors osteoblast-mediated matrix synthesis.

Dosage and Administration Information

This administration guide outlines the steps and schedule for oral administration of the medication, defining the specific protocol for preparation and use.

Official Dosing and Administration

Age Group Daily Dosage Duration
Infants under 6 months 10 mg (1/2 tablet) 10 to 14 consecutive days
Children 6 months to 5 years 20 mg (1 tablet) 10 to 14 consecutive days

Procedural Steps for Oral Use

  1. Preparation: The tablet (or half-tablet) must be placed in a teaspoon and dispersed completely by adding approximately 5 mL (1 teaspoon) of clean water or breast milk.
  2. Administration: The entire spoonful of the dissolved medicine must be administered orally to the child immediately after preparation, without delay.
  3. Timing: Doses are recommended to be given between meals.

Special Procedural Conditions

  • Vomiting: If the child vomits the dose within 30 minutes of administration, the dose must be repeated in full.
  • Missed Dose: If a dose is missed, it should be taken as soon as possible, unless the next dose is due within six hours. Do not take a double dose to compensate for the missed one.
  • Drug Interactions: An interval of at least three hours must be allowed between the administration of this medicine and certain antibiotics (tetracyclines, quinolones) or penicillamine, as co-administration can reduce absorption.

Recent Clinical Evidence

Evidence for Skeletal Health and Mineral Homeostasis (Calcium and Vitamin D3)

Research exploring Calcium and Vitamin D supplementation was studied for its effect on skeletal health, relying on large-scale meta-analyses and long-running observational cohort studies. These studies examined outcomes related to Bone Mineral Density (BMD) measurements and the incidence of non-vertebral fractures over time in older adults and postmenopausal women. Findings related to fracture incidence were mixed and varied across different study populations. The long-term effects on the incidence of fractures in healthy, community-dwelling adults are not fully established.


Evidence for Symptomatic Relief of Digestive Discomfort (Magnesium Hydroxide)

The evidence concerning episodic heartburn and occasional constipation was studied in research exploring how symptoms change over time, primarily using short-term Randomized Controlled Trials (RCTs) and systematic reviews. Studies monitored functional measures like bowel movement frequency and outcomes linked to irritative states. The trials focused on immediate symptomatic change over short durations (e.g., up to four weeks). Comparative evidence is lacking for the full Calzinc formulation.


Evidence for Zinc Supplementation and Key Areas of Uncertainty

Research for Zinc was studied for its effect, focusing on changes in serum Zinc levels and the duration of symptoms during acute infections. Findings were mixed regarding the benefit for common acute infections in individuals whose zinc levels were already considered sufficient. A key area of uncertainty is that most high-quality studies focus on the components separately (e.g., Calcium and Vitamin D together). Data for the full four-component combination (Magnesium, Calcium, Zinc, and Vitamin D3) remain limited, particularly for long-term outcomes and durability of effect.

Key Studies & References

  1. Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation
  2. Zinc for the prevention or treatment of acute viral respiratory tract infections in adults: a rapid systematic review and meta-analysis of randomised controlled trials
  3. AACE/ACE Guidelines: Clinical Practice Guidelines for the Diagnosis and Management of Postmenopausal Osteoporosis

Frequently Asked Questions (FAQ)

Common questions about Calzinc Tablet (FAQ)


Q: How quickly does Calzinc Tablet start to work?

The onset of effect depends on the intended use. For the magnesium hydroxide component, when used as a laxative, official labeling indicates that a bowel movement generally occurs between 30 minutes and 6 hours after administration. The effects related to long-term mineral supplementation (calcium, zinc, and Vitamin D3) are typically gradual and observed over time.


Q: Is Calzinc Tablet taken daily or only as needed?

The administration frequency depends on the product’s intended purpose. For its role as a nutritional supplement to support mineral balance, it is generally intended for daily use. However, when the magnesium hydroxide component is utilized for temporary relief of occasional constipation or heartburn, it may be administered only as needed.


Q: Is it normal to feel a bit tired after starting Calzinc Tablet?

Fatigue and weakness are not listed as common adverse reactions for standard use. However, official safety profiles note these are potential symptoms of elevated mineral levels (e.g., hypercalcemia, or too much calcium in the blood). These symptoms are usually associated with high doses or toxicity. If you experience severe or persistent fatigue, discuss this with a healthcare provider.


Q: Can Calzinc Tablet be crushed or chewed?

Instructions for similar calcium and vitamin D tablets state that swallowing the tablet whole is the standard procedure unless the product is specifically labeled as a 'chewable' or 'dispersible' form. Regulatory guidance requires following the specific instructions provided on the packaging regarding chewing or crushing, as altering the form may change the drug's release properties.


Q: What happens if I miss a dose of Calzinc Tablet?

Official procedural rules advise that a missed dose should be taken as soon as you recall it. However, if the time until your next dose is scheduled to be within six hours, you should skip the missed dose and resume your regular schedule. Regulatory rules advise against taking a double dose to compensate for a missed dose.


Q: Are there any studies or research papers about Calzinc Tablet's effectiveness?

Official research and regulatory assessments primarily focus on the individual components of the tablet (e.g., calcium and Vitamin D together, or zinc alone). Studies available for the full four-component combination are limited, especially concerning long-term outcomes, and effectiveness is often inferred from studies on the individual components.


Q: Can Calzinc Tablet be taken with iron supplements?

Regulatory information indicates that the calcium salts can potentially decrease the absorption of iron. To minimize reduced absorption, official guidance for similar calcium-containing products recommends separating the administration of the tablet and an iron preparation by a minimum of two to four hours.


Q: What are the storage requirements for Calzinc Tablet?

Official labeling requires the product to be stored at a Controlled Room Temperature (20°C–25°C or 68°F–77°F) to ensure stability. It is also essential that the container be kept tightly closed and that the tablets are protected from exposure to both light and moisture.


Q: What is the bioavailability of the nutrients in Calzinc Tablet?

Bioavailability refers to the extent to which the body can absorb the active components. Regulatory studies show that the absorption of minerals, particularly zinc, can be reduced when taken with certain dietary components like high fiber. Official information often suggests taking the tablet between meals to help optimize the absorption of the mineral components.


Q: Is Calzinc Tablet available in liquid form?

Regulatory documents and product descriptions for similar formulations indicate that this combination of mineral and vitamin components may be available as an oral suspension (liquid) in certain markets, in addition to the solid tablet and chewable tablet forms.


Q: Does the absorption of Calzinc Tablet change with age?

Official labeling for the Vitamin D3 component notes that the absorption of the vitamin may be lessened in older individuals compared to younger subjects. This consideration is relevant when determining the appropriate intake of this supplement component.


Q: Can Calzinc Tablet be taken alongside other vitamin D supplements?

When taking other high-dose sources of Vitamin D concurrently, it is important to consider the total cumulative intake of Vitamin D from all sources. Official information notes that exceeding recommended levels can increase the risk of hypercalcemia (too much calcium in the blood).


Q: Is Calzinc Tablet helpful for people with certain malabsorption conditions?

Malabsorption syndrome is often listed as a precaution or contraindication for high-dose forms of the Vitamin D component. Official information suggests that adequate dietary calcium is necessary for the therapy to be effective, implying that underlying malabsorption may limit the expected effects.


Q: Does Calzinc Tablet have different strengths available?

Official regulatory documents show that combination mineral and vitamin supplements are typically produced in different component strengths and various formats, such as suspensions and tablets, to accommodate different therapeutic or nutritional requirements.


Q: Are there any warnings about driving while taking Calzinc Tablet?

Regulatory documents for a key component, Zinc Sulfate, explicitly state that the medicine is not expected to have any known effect on a person’s ability to drive or use machinery. Therefore, it is generally not associated with driving impairment.


Q: Can men and women take the same dose of Calzinc Tablet?

Standard administration guidelines for adults typically apply to both men and non-pregnant women. However, regulatory information specifies that use in pregnant or breastfeeding women requires caution, and intake should not exceed the established Recommended Dietary Allowance (RDA) for those specific groups.


Q: Is there a maximum time limit for taking Calzinc Tablet?

When the product is used specifically for its laxative effect (due to the magnesium hydroxide component), official labeling advises a time limit and states it should not be used for more than one week without consulting a healthcare provider.


Q: Does Calzinc Tablet cause any known weight changes?

The adverse reaction profile for the high-dose forms of the Vitamin D component notes that weight loss can be a metabolic effect. This is typically observed in cases of toxicity or high-dose therapy and is not a common side effect for standard supplementation.


Q: What is Calzinc Tablet commonly prescribed for?

Calzinc Tablet is an Over-the-Counter (OTC) combination product used for a dual therapeutic purpose. It is intended as a nutritional supplement to address deficiencies in its mineral and vitamin components, particularly for bone health. Additionally, the magnesium hydroxide component provides symptomatic relief for episodic heartburn and occasional constipation.


Q: What is the difference between Calzinc and plain Calcium supplements?

Calzinc Tablet is defined as a multimineral formulation. Unlike a plain Calcium supplement, Calzinc combines calcium with three other active components: Magnesium Hydroxide, Zinc, and Vitamin D3. This combination addresses mineral homeostasis while also leveraging the antacid and saline laxative properties of the magnesium salt.


Q: Does Calzinc Tablet require a prescription?

Official product information classifies Calzinc Tablet as an Over-the-Counter (OTC) medicine. This means it is generally widely available and does not require a prescription for purchase.


Q: How does Calzinc Tablet affect the immune system?

The tablet contains zinc, an essential nutrient for immune function. Regulatory research has explored zinc's effect on acute infections. Studies found mixed results regarding the benefit for common acute infections in individuals whose zinc levels were already considered sufficient.


Q: Can children take Calzinc Tablet?

The safety and effectiveness of the complete Calzinc combination product have not been established for pediatric patients under the age of 18. Therefore, the product's general eligibility is restricted to the adult population; pediatric use is not established. If considering its components for children, different formulations or dosages are typically required.


Q: Is there a best time of day to take Calzinc Tablet?

Official administration guidelines recommend that the medicine be taken between meals to help enhance absorption and reduce certain interactions. While there is no specific instruction for morning or night, following the 'between meals' timing is important for adherence to the administration guidelines.


Q: Why do doctors often combine calcium and zinc in one tablet?

The combination is related to their complementary roles in skeletal health. Zinc is known to influence the cellular machinery of bone by stimulating bone-building cells (osteoblasts). Combining it with calcium and Vitamin D supports both bone matrix formation and the modulation of calcium absorption.


Q: What is the purpose of any inactive ingredients in Calzinc Tablet?

Inactive ingredients are components that do not contribute to the therapeutic effect. Their purpose is generally to ensure the correct physical form of the tablet, aid in stability, protect the product from moisture, or assist in the manufacturing and dissolution processes.

How should Calzinc Tablet be stored and disposed of?

How to Store and Dispose of Calzinc Tablet

Official regulatory labeling dictates specific conditions for storing Calzinc Tablet (Calcium Carbonate, Magnesium Hydroxide, Zinc, Vitamin D3) to maintain product stability.

Storage Requirements

Classification Required Condition
Temperature Store at Controlled Room Temperature (20°C–25°C / 68°F–77°F).
Protection The product must be protected from light and moisture; avoid high humidity.
Container Keep the container tightly closed and do not use if the safety seal is broken.
Safety The medicine must be stored out of reach of children.

Liquid formulations should not freeze. Contact with moisture is documented as a stability concern that can discolor or erode the tablet.

Disposal

Official labeling for this over-the-counter product generally provides no specific household or environmental disposal instructions for unused medication. In the event of an overdose, immediately contact a Poison Control Center or get medical help.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Calzinc Tablet found in:

A-Z Index: